GlassScriptPhysician profile
Ron Y Gu
NPI 1851494215
$2,715.41
in general payments reported to CMS, 2019-2025
17 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,161 · 2020: $136 · 2021: $216 · 2022: $160 · 2023: $400 · 2024: $296 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $601.51 | 2019-2025 | Evenity, Prolia |
| Novo Nordisk INC | $567.17 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $255.08 | 2019-2025 | Breztri |
| Janssen Pharmaceuticals, INC | $248.72 | 2019-2023 | Xarelto |
| Glaxosmithkline, LLC. | $191.65 | 2019-2025 | Trelegy Ellipta, Penmenvy, Bexsero |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.61 | 2019-2022 | |
| Lilly USA, LLC | $116.21 | 2019-2024 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $114.58 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Pfizer INC. | $87.42 | 2019-2023 | |
| Radius Health, INC. | $74.29 | 2023-2024 | Tymlos |
| Sanofi Pasteur INC. | $68.39 | 2019-2025 | |
| Esperion Therapeutics, INC. | $63.59 | 2020-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $53.29 | 2019-2023 | |
| Amarin Pharma, INC. | $49.15 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.54 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17.31 | 2019 | |
| Gilead Sciences, INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Gu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.